Polysomnography (Sleep Study): How Nutrition and Fasting Affect Your Results

What Polysomnography Actually Measures

Polysomnography is the reference-standard overnight diagnostic test for sleep disorders. It records electroencephalography (EEG), electro-oculography, chin and leg electromyography, airflow, respiratory effort, pulse oximetry, and body position simultaneously. The American Academy of Sleep Medicine (AASM) defines it as the gold standard for diagnosing obstructive sleep apnea (OSA), central sleep apnea, and many parasomnias. A single night in an accredited lab captures the full picture.

What the Scoring Channels Detect

EEG channels identify sleep stages: N1, N2, N3 (slow-wave sleep), and REM. Airflow thermistors and pressure transducers score apneas and hypopneas. Pulse oximetry logs oxygen desaturation events. Each of these channels responds to physiological changes driven by nutrition, hydration status, and substance intake in the hours before the study.

The Apnea-Hypopnea Index: The Core Metric

The apnea-hypopnea index (AHI) is the number of complete breathing pauses (apneas) plus partial obstructions (hypopneas) per hour of sleep. The AASM 2012 scoring manual defines a hypopnea as a ≥30% reduction in airflow lasting ≥10 seconds with either a ≥3% oxygen desaturation or an EEG arousal. An AHI <5 is considered normal in adults. Values of 5 to 14.9 indicate mild OSA, 15 to 29.9 moderate OSA, and ≥30 severe OSA.

Additional Parameters Clinicians Review

Beyond AHI, a full PSG report includes: sleep efficiency (target ≥85%), REM latency (normal 90 to 120 min), arousal index (normal <10/hour in healthy adults), periodic limb movement index, and the oxygen desaturation index (ODI). Population-level normative data from the Sleep Heart Health Study (N=6,441) showed a median AHI of 4.4 in men and 2.8 in women, establishing community reference distributions that remain widely cited today.

How Alcohol Disrupts Polysomnography Findings

Alcohol is the single most consequential dietary variable before a PSG. Even one to two standard drinks consumed within three hours of bedtime produces measurable distortions across multiple channels.

First-Half vs. Second-Half Architecture Shift

Ethanol accelerates sleep onset and suppresses REM during the first 3 to 4 hours of sleep. As alcohol metabolizes in the second half of the night, REM rebounds excessively while N3 collapses. A controlled crossover study (N=24) published in Alcoholism: Clinical and Experimental Research documented a 39% reduction in REM during the first half of the night after moderate alcohol intake, paired with a compensatory REM rebound that inflated REM percentage in the second half. A PSG scored under these conditions may misrepresent true REM latency and REM percentage.

Alcohol Worsens Airway Collapsibility

Ethanol relaxes pharyngeal dilator muscles, directly increasing upper-airway resistance. Peppard et al. In the Wisconsin Sleep Cohort found that alcohol consumption in the evening was associated with a significantly higher AHI the same night, with AHI increases in the range of 25% over each subject's baseline. For a patient near the 15-event-per-hour threshold between mild and moderate OSA, this pharmacological effect could push the study into a higher severity category that does not reflect their sober baseline.

Clinical Instruction

Patients should abstain from all alcohol for a minimum of 24 hours before a polysomnography study. Some labs and the AASM clinical practice guidelines for diagnostic testing recommend 48 hours of abstinence for patients with a known history of heavy drinking.

Caffeine: Half-Life, Dose, and Study Timing

Caffeine's effects on PSG are dose-dependent and governed by its pharmacokinetics. The plasma half-life of caffeine in healthy adults averages 5 to 6 hours, though CYP1A2 polymorphisms can extend it to 9 to 10 hours in slow metabolizers. A double-blind, placebo-controlled trial (N=16) in the Journal of Sleep Research showed that 200 mg of caffeine consumed 6 hours before bedtime reduced total sleep time by 41 minutes and reduced sleep efficiency by 7 percentage points compared to placebo.

What Caffeine Does to PSG Channels

Caffeine delays sleep onset, reduces N3 percentage, reduces total sleep time, and can produce a falsely elevated arousal index. On a PSG report, these changes mimic insomnia or insufficient study duration. If the recorded sleep period falls below 6 hours because caffeine delayed sleep onset, AASM scoring standards flag the study as potentially inadequate for reliable AHI calculation.

Recommended Cutoff

Stop all caffeine-containing beverages and foods (coffee, tea, energy drinks, cola, dark chocolate in meaningful quantities) by noon on the day of the study if lights-out is scheduled for 10 to 11 PM. For studies scheduled earlier in the evening, back-calculate a cutoff using 8 hours before projected sleep onset as a conservative buffer.

Meal Timing, Macronutrient Composition, and Sleep Architecture

High-Carbohydrate vs. High-Fat Meals

Macronutrient composition influences sleep architecture through several mechanisms: insulin-driven tryptophan transport, postprandial thermogenesis, and gut-derived signaling peptides. A randomized crossover study published in the American Journal of Clinical Nutrition (N=26) found that a high-glycemic-index meal consumed four hours before sleep shortened REM latency by approximately 48% relative to a low-GI meal. REM latency on the high-GI night averaged 46.5 minutes versus 87.1 minutes on the low-GI night, a difference large enough to shift interpretation of whether a patient has abnormally short REM latency.

Heavy Meals and Upper-Airway Mechanics

Gastric distension after a large meal elevates the diaphragm, reduces functional residual capacity, and increases the risk of obstructive events in the supine position. Patients with central obesity or a high neck circumference are especially susceptible. Finishing the last meal at least three hours before the scheduled study start reduces postprandial gastric volume to a level where its mechanical effects on airway patency are minimal.

Protein and Tryptophan Considerations

Tryptophan is the amino acid precursor to serotonin and melatonin. A moderate-protein dinner (20 to 30 g protein) may support endogenous melatonin synthesis without the gastric distension associated with large protein loads. No preparation protocol calls for high-dose tryptophan supplementation before PSG, as this could artificially shorten REM latency and affect the study's validity.

Supplements, Medications, and PSG Validity

Melatonin

Exogenous melatonin taken on the night of a PSG shortens sleep-onset latency and can advance the circadian timing of REM sleep. A meta-analysis of 19 trials (N=1,683) in PLOS ONE found melatonin reduced sleep-onset latency by 7.06 minutes (95% CI: 4.37 to 9.75, P<0.001). While this effect sounds modest, in a patient who would otherwise lie awake for 45 to 60 minutes, melatonin changes the relationship between lights-out time and actual sleep onset in ways that affect REM latency calculation and overall study architecture.

Patients should disclose all supplement use to the ordering clinician before the study. Whether to hold melatonin depends on the clinical question: if the study is purely for OSA screening, melatonin is less problematic; if circadian phase or REM behavior disorder is under investigation, hold melatonin for at least 72 hours.

Sedating Antihistamines and Cannabis

Diphenhydramine (Benadryl) and doxylamine suppress REM and N3, closely mimicking benzodiazepine effects. The AASM's 2017 clinical practice guideline on chronic insomnia notes that antihistamines alter EEG frequency patterns in ways that complicate sleep-stage scoring. Cannabis (THC) suppresses REM dose-dependently. Patients using either substance should notify their sleep lab in advance.

Magnesium and B-Complex Vitamins

Standard doses of magnesium glycinate (200 to 400 mg) or a B-complex vitamin are unlikely to produce clinically meaningful PSG distortions. No controlled trials have documented significant PSG-channel effects at typical supplement doses. These do not require discontinuation unless the clinician has a specific reason for concern.

Hydration Status and Nasal Congestion

Dehydration thickens upper-airway secretions and increases mucosal resistance. Nasal congestion, whether from dehydration, a recent high-sodium meal, or allergic rhinitis, forces a shift to oral breathing. A study in CHEST (N=408) found that nasal obstruction independently increased AHI by a mean of 8.2 events per hour compared to unobstructed nights in the same patients. Adequate hydration (2 to 2.5 liters of water spread through the day) and avoidance of excessively salty foods in the 24 hours before the study reduces this confounder.

Patients should not drink large volumes of fluid in the two hours before study start, however. Nocturia interrupts the recorded sleep period and reduces effective study duration below the minimum needed for valid AHI scoring.

Body Weight, Obesity, and OSA Risk: Why Nutrition Matters Beyond One Night

A single night's dietary preparation matters less than chronic nutritional patterns that determine body weight and adiposity. The relationship between obesity and OSA is dose-response in character. The Sleep Heart Health Study reported that each 10 kg increase in body weight was associated with approximately a 32% increase in OSA odds. The STEP-1 trial (N=1,961) demonstrated that semaglutide 2.4 mg weekly produced 14.9% mean weight loss at 68 weeks versus 2.4% with placebo (P<0.001). In the SURMOUNT-OSA trials, tirzepatide produced a 55.0% reduction in AHI at 52 weeks in patients not using CPAP, reducing mean AHI from 51.5 to 23.8 events per hour. These results were published in the New England Journal of Medicine in 2024.

GLP-1 Receptor Agonists and OSA

The FDA approved tirzepatide (Zepbound) in June 2024 specifically for moderate-to-severe OSA in adults with obesity, marking the first pharmacological approval for OSA itself. Weight loss through caloric restriction, structured exercise, or GLP-1 receptor agonist therapy remains the only intervention that addresses both the root cause of obesity-driven OSA and the downstream PSG findings. CPAP treats the nightly manifestation; weight loss can eliminate it.

A Pre-Study Nutritional Preparation Framework

The table below consolidates evidence-based preparation steps by variable, timing, and rationale. Use it as a clinical decision aid for counseling patients before PSG.

| Variable | Instruction | Primary Rationale | |---|---|---| | Alcohol | Abstain ≥24 h (≥48 h in heavy drinkers) | AHI elevation, REM suppression, REM rebound | | Caffeine | Stop ≥8 h before projected sleep onset | Sleep-onset delay, N3 reduction, arousal index inflation | | Last meal | ≥3 h before study start | Diaphragm elevation, upper-airway resistance | | Meal GI | Low-to-moderate glycemic index preferred | Avoid artificially shortened REM latency | | Protein | 20 to 30 g at dinner | Tryptophan precursor support without gastric distension | | Hydration | 2 to 2.5 L water through the day; none in final 2 h | Nasal congestion reduction, nocturia avoidance | | Melatonin | Disclose; hold 72 h if circadian question is primary | REM timing distortion | | Sedating antihistamines | Hold night-of dose; discuss with prescriber | EEG suppression, N3/REM reduction | | Cannabis (THC) | Disclose use; hold ≥24 h where clinically feasible | REM suppression |

OSA Screening in TRT and Hormone-Therapy Patients

Testosterone replacement therapy (TRT) increases upper-airway collapsibility and is a recognized risk factor for OSA onset or worsening. Liu et al., in the Annals of Internal Medicine, documented that exogenous testosterone worsened nocturnal hypoxemia in older men, with mean oxygen nadir dropping from 87% to 81% after 12 weeks of testosterone treatment. The Endocrine Society's 2018 clinical practice guideline on male hypogonadism states: "We recommend that clinicians measure hematocrit and assess symptoms of sleep apnea before initiating testosterone therapy and at 3 to 6 months after starting treatment." Available at the Endocrine Society's guidelines portal.

Patients starting or adjusting TRT doses should receive baseline PSG screening if they carry OSA risk factors: BMI ≥30, neck circumference ≥17 inches in men, witnessed apneas, or an Epworth Sleepiness Scale score ≥10. Nutritional preparation for this screening PSG follows the same protocol as any diagnostic study, with the added requirement to record the most recent testosterone dose and injection or gel application date on the lab intake form.

Estrogen, Progesterone, and Sleep Architecture in Women

Postmenopausal women lose the airway-protective effects of progesterone. Young et al. In the American Journal of Respiratory and Critical Care Medicine reported that postmenopausal women not on hormone therapy had 3.5 times the OSA prevalence of premenopausal women. Progesterone stimulates respiratory drive; estrogen reduces upper-airway resistance. Women undergoing PSG in the context of HRT evaluation should ideally be studied at a consistent point in their HRT cycle, and the timing of the last dose should be recorded.

Reading Your PSG Report: Normal Ranges at a Glance

A PSG report contains more parameters than AHI alone. Here are the reference values clinicians use to assess a complete study:

| Parameter | Normal / Target Value | Source | |---|---|---| | AHI | <5 events/hour | AASM Scoring Manual 2012 | | Sleep efficiency | ≥85% | AASM normative data | | REM latency | 90 to 120 minutes | Standard polysomnographic norms | | N3 (slow-wave sleep) % | 10 to 20% of total sleep time in adults | AASM normative data | | REM % | 20 to 25% of total sleep time | AASM normative data | | Arousal index | <10/hour | AASM Scoring Manual | | Oxygen desaturation index (ODI) | <5 events/hour | AASM guidelines | | Mean SpO2 | ≥95% | Clinical consensus | | Nadir SpO2 | ≥88% | OSA severity threshold | | PLMI (periodic limb movement index) | <15/hour (clinical threshold) | AASM practice parameters |

The AASM publishes its updated scoring rules and normative data through its guidelines portal.

What Happens When Nutritional Preparation Is Inadequate

An inadequately prepared PSG study produces one of three clinical problems. First, a false negative: alcohol or a very large meal suppresses respiratory effort enough to miss clinically significant OSA in a patient who genuinely needs CPAP. Second, a false positive in severity: alcohol inflates AHI, pushing a patient from mild to moderate and triggering CPAP initiation that may be unnecessary on sober nights. Third, an invalid study: excessive caffeine or early waking from nocturia reduces total recorded sleep below the 6-hour minimum AASM considers necessary for reliable AHI scoring, requiring a repeat study.

Repeat studies carry a mean out-of-pocket cost of $1,200, $3,500 for in-lab PSG according to CMS reimbursement data, plus the indirect costs of delayed diagnosis. One properly prepared study is clinically and economically preferable to two.